Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지

Group B Streptococcal Disease in Korean Neonates

한국 신생아에서 B군 사슬알균 감염증

  • Oh, Chi Eun (Department of Pediatrics, Kosin University College of Medicine)
  • 오지은 (고신대학교 의과대학 소아과학교실)
  • Received : 2012.06.26
  • Accepted : 2012.08.02
  • Published : 2012.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Group B streptococcus (GBS) is the leading cause of neonatal sepsis and meningitis in developed countries. This article reviews the neonatal invasive GBS disease, maternal GBS colonization, and prevention strategies in the context of recent epidemiological changes in Korea. Although Korean neonates had been supposed to have low incidence of invasive GBS disease, GBS has been recently reported to be the most common cause of invasive neonatal infection after 1990s. Among Korean pregnant women, GBS carriage rate in the vagina and rectum has been reported to be much lower than that in Western countries. However, it has increased in recent studies. For decision making about preventive strategy for neonatal GBS disease in Korea, further studies are required in terms of the incidence of neonatal GBS infection and serotype distribution. In addition, studies about maternal carriage rate and serotype distribution have to be continued.

Keywords

References

  1. Edwards MS, Baker CJ.Streptococcus agalactiae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 3rd ed. Philadelphia : Elsevier. Churchill Livingstone, 2005:2423-34.
  2. Edward MS, Nizet V, Baker CJ. Group B streptococcal infection. In: Remington JS, Klien JO, Baker CJ, Wilson CB, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia : WB Saunders Co, 2006: 1091-141.
  3. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983;148:802-9.
  4. Hood M, Janney A, Dameron G. Beta hemolytic streptococcus group B associated with problems of the perinatal period. Am J Obstet Gynecol 1961;82:809-18.
  5. Baker CJ, Barrett FF. Transmission of group B streptococci among parturient women and their neonates. J Pediatr 1973;83:919-25.
  6. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-18.
  7. Kim KA, Shin SM, Choi JH. A nationwide survey on the causative organisms of neonatal sepsis in Korea. J Korean Pediatr Soc 2002;45:55-63.
  8. Lee JH, Cho HK, Kim KH, Kim CH, Kim DS, Kim KN, et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter study. J Korean Med Sci 2011;26:174-83.
  9. Baker CJ, Barrett FF. Group B streptococcal infections in infants. The importance of the various serotypes. JAMA 1974;230:1158-60.
  10. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65.
  11. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intra-partum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
  12. Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010;37:375-92.
  13. Edwards MS, Baker CJ.Streptococcus agalactiae (Group B Streptococcus). In: Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious diseases revised reprint, 3rd ed. Philadelphia : Elsevier, Churchill Livingstone, 2009:711-6.
  14. Godambe S, Shah PS, Shah V. Breast milk as a source of late onset neonatal sepsis. Pediatr Infect Dis J 2005;24:381-2.
  15. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999;104:203-9.
  16. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000;96:498-503.
  17. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-5.
  18. Kim MW, Jang HO, Chang DY, Cho JR, Kim YA, Choi HM, et al. Group B streptococcal colonization rate in Korean pregnant women. Korean J Obstet Gynecol 2006;49:337-44.
  19. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC . Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis 1997;16:753-6.
  20. Uh Y, Kwon JY, Jang IH, Yoon KJ, Kim HK. Colonization rate of group B streptococcus in pregnant women and neonates. Korean J Clin Pathol 1994;14:447-53.
  21. Park LS, Seo K, Kim SK, Park YW, Jung HY, Chong YS, et al. A study of group B streptococcal infection in Korean pregnant women. Korean J Obstet Gynecol 1999;42:2038-42.
  22. Uh Y, Choi SJ, Jang IH, Lee KS, Cho HM, Kwon O, et al. Colonization rate, serotypes, and distributions of macrolide-lincosamide-streptograminB resistant types of group B streptococci in pregnant women. Korean J Clin Microbiol 2009;12:174-9.
  23. Oh CE, Jang HO, Kim NH, Lee J, Choi EH, Lee HJ. Molecular serotyping of group B streptococcus isolated from the pregnant women by polymerase chain reaction and sequence analysis. Korean J Pediatr Infect Dis 2009;16:47-53.
  24. Hong JS, Choi CW, Park KU, Kim SN, Lee HJ, Lee HR, et al. Genital group B streptococcus carrier rate and serotype distribution in Korean pregnant women: implications for group B streptococcal disease in Korean neonates. J Perinat Med 2010;38:373-7.
  25. Yun HK, Song PJ, Choi KC, Ju JR, Cho BS, Jung SJ. A case of neonatal meningitis by group B streptococcus. J Korean Pediatr Soc 1984;27:1011-7.
  26. Kim YK, Kwak YH, Kim YJ, Jung HS, Hong JY, Lee HJ. Clinical features of group B $\beta$-hemolytic streptococcal infection in infants and children. Korean J Pediatr Infect Dis 1999; 6:194-202.
  27. Kim HJ, Lee JW, Lee KY, Lee HS, Hong JH, Han SH. Causative organisms in children with bacterial meningitis (1992-2002). J Korean Pediatr Soc 2003;46:1085-8.
  28. Cho HK, Lee H, Kang JH, Kim KN, Kim DS, Kim YK, et al. The causative organisms of bacterial meningitis in Korean children in 1996-2005. J Korean Med Sci 2010;25:895-9.
  29. Centers for Disease Control and Prevention. Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb Mortal Wkly Rep 2009;58:09-12.
  30. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057-64.
  31. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012;379:547-56.
  32. Kim JS, Jang YT, Kim JD, Park TH, Park JM, Kilgore PE, et al. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children. Vaccine 2004;22:3952-62.
  33. Lee JH, Kim SM, Lee HS, Kim SY, Choi SD, Sung IK, et al. A clinical study of group B streptococcal infection: five year experience. J Korean Soc Neonatol 2003;10:228-34.
  34. Park KH, Kim KH, Kang JH, Kim KN, Kim DS, Kim YK, et al. Current status and clinical presentations of invasive neonatal group B streptococcal infections in Korea. Pediatr Int 2011;53:236-9.
  35. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed newStreptococcus agalactiae serotype. J Clin Microbiol 2007;45:2929-36.
  36. Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, et al. Changing Molecular Epidemiology of Group B Streptococcus in Korea. J Korean Med Sci 2010;25:817-23.
  37. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
  38. Lim DV, Morales WJ, Walsh AF, Kazanis D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986;23:489-92.
  39. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996;45(RR-7):1-24.
  40. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
  41. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations-United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007;56:701-5.
  42. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59(RR-10):1-36.
  43. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin B Streptococcus. Obstet Gynecol 1998;91:112-4.
  44. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204-10.
  45. Fiore Mitchell T, Pearlman MD, Chapman RL, Bhatt- Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001;98:1075-9.
  46. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001;345:804-9.
  47. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626-36.
  48. Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect 2011;17:1294-303
  49. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6.
  50. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003;21:3468-72.
  51. Baker C, Edwards M. Group B streptococcal conjugate vaccines. Arch Dis Child 2003;88:375-8.
  52. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-50.
  53. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, Hickman ME, et al. Use of capsular polysaccharidetetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis 2000;182:1129-38.
  54. Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009;199:108-15.
  55. Choi KU, Koh SK, Lee JY, Park JH, Hwang SO, Lee BI, et al. Clinical Significance of Group B Streptococcal Infection in Pregnant Women. Korean J Obstet Gynecol 2002;45:811-5.
  56. Lee SH, Park KU, Lee HK, Kim MY, Kim JY, Kwon WK, et al. Perineal colonization rate and antimicrobial susceptibility of group B streptococcus in pregnant and non-pregnant Korean women. Korean J Clin Microbiol 2009;12:180-5. https://doi.org/10.5145/KJCM.2009.12.4.180
  57. Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, et al. Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci 2010;25: 817-23. https://doi.org/10.3346/jkms.2010.25.6.817
  58. Pannaraj PS, Baker CJ. Group B streptococcal infections. In: Feigin RD, Cherry J, Demmeler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's textbook of pediatric infectious diseases, 6th ed. Philadelphia : WB Saunders Co, 2009:1239-57.
  59. Swingle HM, Bucciarfelli RL, Ayoub EM. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis 1985; 152:515-20. https://doi.org/10.1093/infdis/152.3.515